Nairobi, Kenya. Kenya has reaffirmed its commitment to vaccine self-reliance and preventive healthcare during the 16th KEMRI Annual Scientific and Health (KASH) Conference. This event gathered government officials, researchers, and global health partners to discuss urgent public health challenges.
During the conference, government representatives stressed the critical need for Kenya and other African nations to achieve vaccine independence. They highlighted the lessons learned from the COVID-19 pandemic.
Lessons from COVID-19
The COVID-19 crisis from 2019 to 2021 revealed significant global inequalities in vaccine access. Countries with manufacturing capabilities secured doses quickly, while many African countries struggled to obtain supplies.
“That is when we realized we must be self-reliant on matters as critical as vaccines,” one official noted at the conference.
Vaccines have saved over 150 million lives worldwide in the last 50 years. They have significantly lowered child mortality and reduced the burden on healthcare systems. Officials pointed out that early childhood vaccination not only saves lives but also cuts long-term healthcare costs, generating billions of shillings in savings for governments.
The government promised to strengthen collaboration with research institutions like KEMRI to boost vaccine research, production capacity, and implementation frameworks.
After the conference, a high-level meeting will take place to identify the main challenges in the vaccine and health research sectors and suggest practical solutions.
From Research to Implementation
While recognizing Kenya’s well-regarded research institutions, including KEMRI and its partners, speakers emphasized that the nation must now concentrate on applying existing knowledge.
“We don’t necessarily need more research. Many solutions already exist. What we need is better coordination between academia, government, industry, and health systems,” one speaker said.
Bridging gaps between these sectors should speed up progress in vaccine development, manufacturing, and delivery.
Prevention as the Most Cost-Effective Strategy
A key topic at the conference was preventive healthcare. Experts underscored that vaccines and environmental health measures are among the most cost-effective strategies available.
Researchers studying environmental transmission of infectious diseases highlighted the need for improved water quality, sanitation, and hygiene to lessen the disease burden.
Preventing early exposure to pathogens in children can drastically reduce infection rates, lower antibiotic use, and slow the rise of antimicrobial resistance (AMR).
By decreasing disease incidence, fewer antibiotics are needed, which lessens the selective pressure that creates resistant bacteria strains.
Neonatal Infections and Antimicrobial Resistance
One major concern addressed at the conference was the rising threat of drug-resistant infections among newborns.
A postdoctoral researcher from the KEMRI-Wellcome Trust Research Programme in Kilifi shared findings from over 20 years of hospital surveillance data focused on neonatal infections, especially among premature and low birth weight infants who need extended hospital care.
The data indicates that newborns are very vulnerable to bacterial infections contracted in hospitals. Alarmingly, many of these infections are caused by antibiotic-resistant bacteria.
Local vaccine manufacturing seen as economic and security imperative for Kenya
One of the top pathogens identified is Klebsiella pneumoniae, linked to repeated outbreaks in Kenyan hospitals, including cases at Kenyatta National Hospital.
Mortality rates among infected newborns can exceed 20 percent in certain environments.
The researcher explained that limited diagnostic capabilities in public hospitals pose a significant challenge. Even though many facilities have labs, they often lack advanced equipment, reagents, and specialized expertise required to quickly detect and monitor resistant bacteria strains.
To tackle this, researchers are employing genomic sequencing techniques to analyze the DNA of Klebsiella pneumoniae strains. The aim is to identify the most prevalent and dangerous types and use that information to create a targeted maternal vaccine.
A Maternal Vaccine Strategy
The suggested strategy involves vaccinating expectant mothers. Once vaccinated, mothers would develop immunity to specific bacterial strains. They could then pass protective antibodies to their newborns during pregnancy, lowering the risk of severe infection immediately after birth.
Although a vaccine has not yet been developed, researchers believe that understanding the dominant bacterial strains is a vital first step.
Experts also stressed that infection prevention and control measures in hospitals remain crucial. However, resource limitations continue to hinder full implementation in many facilities.
A Unified Approach
The conference highlighted that addressing infectious diseases and antimicrobial resistance requires an all-encompassing approach: vaccines, improved diagnostics, better hospital infection control, environmental health interventions, and enhanced inter-sectoral collaboration.
As Kenya aspires to be a regional leader in medical research and public health innovation, stakeholders agree that preventive strategies—especially vaccination and sanitation—will be essential to building a resilient healthcare system.
The message from the KEMRI conference was clear: prevention is not just lifesaving—it is also financially wise, scientifically attainable, and vital for Kenya’s long-term health security.
